Details the physiology related to alcohol consumption and its subsequent impact on drug release. Effective formulation strategies for meeting the physiological and regulatory challenges for developing alcohol-resistant modified release (MR) oral drug products. Formulation concepts using EUDRAGIT® polymers will be presented to demonstrate how robust MR formulations with improved alcohol resistance can be developed for both matrix and coated multiparticulate dosage forms.
Dr. Firouz Asgarzadeh
Director Technical Services, Pharma Polymers & Services N.A
Moderator Nick Taylor
Professor Dr. Clive G. Wilson
J. P. Todd Professor of Pharmaceutics
University of Strathclyde